Fact CheckerSign in

NCT07606768Enrolling by invitation

The Effect of Nurse-led Health Coaching on Blood Pressure Control and Disease Self-management Among Patients With Hypertension in Huayuan County, Western Hunan, China: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 26 May 2026

Brief summary (registry, in English)

Background: Effective self-management of hypertension (HTN) is the key to adequate blood pressure control. The self-management education for patients with HTN has not been widely provided in Huayuan County, Western Hunan, China. Health coaching is a goal-oriented, client-centered partnership focused on a process of client enlightenment and empowerment which has shown to be effective in improving self-management behaviors. However, little is known whether such intervention is effective for adults with newly diagnosed with HTN in Huayuan County, Western Hunan, China. The aims of the study are to examine the effect of nurse-led health coaching on controlling BP and improving self-management among patients with HTN in Huayuan County Western Hunan, China. We will conduct a single-center six-month, two-arm randomized controlled trial (RCT) at the outpatient department of Huayuan County People's Hospital. It will recruit 78 participants with HTN. The control group received health guidance and follow-up management, the experimental group received health coaching and follow up management in addition to the usual care. The intervention content was divided into three parts. The initial stage, the core stage and the maintenance stage, respectively, which included ten steps. After obtaining participants' participant informed consent, baseline data were collected, at month 1, month 3 and month 6 after the intervention, the participants were asked to fill in the questionnaires again when they came to the hospital for follow-up. The primary outcomes were the difference in changes of blood pressure, medication literacy and self-management scores. The secondary outcomes included body mass index (BMI), waist circumference (WC).Once the intervention is confirmed to be effective, we will implement the health coaching in the control group.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
39 (estimated)
First submitted
19 May 2026
Start date
1 Nov 2025
Primary completion date
31 Dec 2026
Lead sponsor
The Third Xiangya Hospital of Central South University
NCT number
NCT07606768

What you commit to

  • Study type: Interventional
  • Planned participants: 39
  • From 1 Nov 2025 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • An inability to understand and provide informed consent (e.g., people with cognitive problems or thought disorder);
  • New York Heart Association class Ior IV heart failure;
  • A medical condition that precludes adherence to medical recommendations (e.g., end stage cancer, active severe mental illness)

Other

  • Actively requesting with drawal during the research process.

Who the study is looking for

  • (1)Age≥18 years old, age ≤ 85 years and free of language communication barriers (2)Diagnosis with Stage 2 HTN (systolic blood pressure \>140 and or diastolic\>90) ; (3)Taking at least 1 anti-hypertensive medication;Taking anti-hypertensive drugs for ≥ 2 weeks; (4) having a mobile phone or landline phone.

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
the outpatient department of Huayuan County People's Hospital
Coordinator of this site? Confirm its status
HuayuanChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.